demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 prophylaxis (excluding children)
Sinopharm Beijing (BBIBP-CorV) Xia ... Kanokudom

5 studies excluded by filtering options 1

9216 Sultan, 2022 0120selection pending
9226 Tawinprai, 2022 2100excludednot a RCTrisk of bias not avaialble
9463 Ashmawy, 2022 1110not a RCTrisk of bias not avaialble
9490 Greish, 2022 2100excludednot a RCTrisk of bias not avaialble
9614 Rearte, 2022 0120selection pending